Sarepta Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSarepta Therapeutics
Sarepta Therapeutics logo

Sarepta Therapeutics

0 followers

SRPT

Performance

About Sarepta Therapeutics

Sarepta Therapeutics is a global biotechnology company focused on precision genetic medicines to treat rare neuromuscular and central nervous system diseases. The company is advancing gene therapy and RNA-based approaches with an emphasis on Duchenne muscular dystrophy and related rare disorders, and is building manufacturing capacity to speed patient access. Headquartered with global operations, Sarepta collaborates across scientists, patients, and partners to bring transformative therapies to underserved populations.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Ian M. Estepan

President and Chief Operating Officer

Douglas S. Ingram

Chief Executive Officer

Ryan H. Wong

Executive Vice President, Chief Financial Officer

Louise R. Rodino-Klapac, PhD

President, R&D and Technical Operations

Diane Berry, PhD

Executive Vice President, Chief Global Policy & Advocacy Officer

Key Facts

HQ Location

Cambridge, United States

Founded

1980

Employees

1K-5K

Status

Public

Website

https://sarepta.com